


文档简介
1、 HYPERLINK https:/www.MedChemE/Targets/cd73.html CD73ecto-5-nucleotidase, NT5ECD73 (Ecto-5-nucleotidase) is a 70-kD glycosylphosphatidyl inositol (GPI)-anchored cell surface protein encoded by the NT5E genethat plays a crucial role in switching on adenosinergic signaling. CD73 is an ectonucleotidase
2、 which catalyzes the terminal step inextracellular adenine nucleotide breakdown: the conversion of AMP to adenosine. Adenosine, which binds to a discrete family ofcell surface receptors to initiate intracellular signaling cascades, has been shown to be anti-inflammatory and vasorelaxant.CD73 has bot
3、h enzymatic and non-enzymatic functions in cells: as a nucleotidase, CD73 catalyzes the hydrolysis of AMP intoadenosine and phosphate, and CD73-generated adenosine plays an important role in tumor immunoescape; moreover, CD73 alsofunctions as a signal and adhesive molecule that can regulate cell int
4、eraction with extracellular matrix components, such as lamininand fibronectin, to mediate the invasive and metastatic properties of cancers. Both the enzymatic and non-enzymatic functions ofCD73 are involved in cancer-associated processes and are not completely independent of each other. There is am
5、ple evidence toshow that CD73 is a key regulatory molecule in cancer development and is overexpressed in many cancers, including leukemia,glioblastoma, melanoma, ovarian cancer, esophageal cancer, prostate cancer and breast cancer.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/cd73.html CD73 H
6、YPERLINK https:/www.MedChemE/Targets/cd73.html HYPERLINK https:/www.MedChemE/Targets/cd73.html Inhibitors HYPERLINK https:/www.MedChemE/AB-680.html AB-680 HYPERLINK https:/www.MedChemE/AB-680.html HYPERLINK https:/www.MedChemE/ab-680-ammonium.html AB-680 HYPERLINK https:/www.MedChemE/ab-680-ammonium
7、.html HYPERLINK https:/www.MedChemE/ab-680-ammonium.html ammoniumCat. No.: HY-125286 Cat. No.: HY-125286AAB-680 is a highly potent, reversible andselective inhibitor of CD73 (anecto-nucleotidase), with a K of 4.9 pM for hCD73,idisplays 10,000-fold selectivity over relatedecto-nucleotidases CD39. Ant
8、i-tumor activity.AB-680 ammonium is a highly potent, reversible andselective inhibitor of CD73 (anecto-nucleotidase), with a K of 4.9 pM for hCD73,idisplays 10,000-fold selectivity over relatedecto-nucleotidases CD39. Anti-tumor activity.Purity: 99.71%Clinical Data: Phase 2Size: 10 mM 1 mL, 5 mg, 10
9、 mg, 25 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/CD73-IN-1.html CD73-IN-1 HYPERLINK https:/www.MedChemE/CD73-IN-1.html HYPERLINK https:/www.MedChemE/cd73-in-2.html CD73-IN-2Cat. No.: HY-103695 Cat. No.: HY-131435CD73-IN-1 is an
10、inhibitor of CD73 which can beused in the treatment of cancer extracted frompatent WO 2017153952 A1, example 80.CD73-IN-2 is a potent CD73 inhibitor extractedfrom WO2020151707A1, example 1, has an IC of500.09 nM.Purity: 98.54%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mg,
11、 25 mg, 50 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/cd73-in-3.html CD73-IN-3 HYPERLINK https:/www.MedChemE/cd73-in-3.html HYPERLINK https:/www.MedChemE/cd73-in-4.html CD73-IN-4Cat. No.: HY-137246 Cat. No.: HY-131967CD73-IN-3 is a potent CD73 i
12、nhibitor (IC =7.3 nM50in Calu6 human cell assay). CD73-IN-3, example 2extracted from patent WO2019168744 A1, has thepotential for cancer research.CD73-IN-4 is a potent and selectivemethylenephosphonic acid CD73 inhibitor, with anIC of 2.6 nM for human CD73. CD73-IN-4 is50potential for the research o
13、f cancer immunology.Purity: 99.89%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.54%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/cd73-in-5.html CD73-IN-5 HYPERLINK https:/www.MedChemE/
14、cd73-in-5.html HYPERLINK https:/www.MedChemE/cd73-in-6.html CD73-IN-6Cat. No.: HY-145334 Cat. No.: HY-144209CD73-IN-5 is a potent and selective non-nucleotidesmall molecule inhibitor of CD73 (IC = 19 nM).50CD73-IN-6 is a CD73 inhibitor extracted frompatent WO2022007677A1 compound 2. CD73-IN-6 can be
15、used for the research of cancer.Purity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/MethADP.html MethADP HYPERLINK https:/www.MedChemE/MethADP.html HYPERLINK https:/www.MedChe
16、mE/methadp-sodium-salt.html MethADP HYPERLINK https:/www.MedChemE/methadp-sodium-salt.html HYPERLINK https:/www.MedChemE/methadp-sodium-salt.html sodium HYPERLINK https:/www.MedChemE/methadp-sodium-salt.html HYPERLINK https:/www.MedChemE/methadp-sodium-salt.html salt(Adenosine 5-(,-methylene)diphosp
17、hate) Cat. No.: HY-112502Cat. No.: HY-112502BMethADP is a specific CD73 inhibitor.MethADP (sodium salt) is a specific CD73inhibitor.Purity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909
18、 Email: salesMedChemE HYPERLINK https:/www.MedChemE/mrs4620.html MRS4620Cat. No.: HY-144072 HYPERLINK https:/www.MedChemE/oleclumab.html Oleclumab(MEDI9447) Cat. No.: HY-P99039MRS4620 is a potent CD73 inhibitor, with a K ofi0.436 nM. MRS4620 can be use for the research ofcancer immunotherapy.Oleclum
19、ab (MEDI9447) is a human IgG1 anti-CD73monoclonal antibody that inhibits CD73 function.Oleclumab has an anti-tumor activity.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/op-5244.html OP
20、-5244 HYPERLINK https:/www.MedChemE/op-5244.html HYPERLINK https:/www.MedChemE/op-5244-sodium.html OP-5244 HYPERLINK https:/www.MedChemE/op-5244-sodium.html HYPERLINK https:/www.MedChemE/op-5244-sodium.html sodiumCat. No.: HY-136978 Cat. No.: HY-136978AOP-5244 is a potent and orally active inhibitor
21、 ofCD73, with an IC of 0.25 nM. OP-5244 reverses50immunosuppression through blocking of adenosineproduction, and has the potential for the cancerresearch.OP-5244 sodium is a potent and orally activeinhibitor of CD73, with an IC of 0.25 nM.50OP-5244 sodium reverses immunosuppression throughblocking o
22、f adenosine production, and has thepotential for the cancer research.Purity: 99.63%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mgPurity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg HYPERLINK https:/www.MedChemE/PSB-12379.html PSB-12379 HYPERLINK https:/www.MedChemE/PSB-12379.html HYPERLINK https:/www.MedChemE/psb-12379-disodium.html PSB-12379 HYPERLINK https:/www.MedChemE/psb-12379-disodium.html HYPERLINK https:/www.MedChemE/psb-12379-disodium.html disodiumCat. No.: HY-100
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 铁路客运管理课件
- 临床检验考试题和答案2025版
- 临床检验分子诊断学试题及答案2025版
- 采暖系统项目投资可行性研究分析报告(2024-2030版)
- 2025-2030年中国软胶玩具项目投资可行性研究分析报告
- 2025年中国有机蜂产品市场运行态势及投资战略咨询研究报告
- 电动小车葫芦行业深度研究分析报告(2024-2030版)
- 幼儿园安全教育主题方案模板
- 中国智能水杯行业市场运行态势及投资战略咨询研究报告
- 儿科护士个人工作方案报告(模板)
- 2025中国成人ICU镇痛和镇静治疗指南解读
- 大学生心理健康十六讲(第3版) 课件 樊富珉 第1讲 心理健康知多少-大学生心理健康导论-第7讲 人际关系你我他-人际交往
- 8.3+动能和动能定理+课件-2024-2025学年高一下学期物理人教版(2019)必修第二册
- 肾结石患者的护理
- 公园水面安全管理办法
- 吉林延边州汪清县公安局招聘留置看护警务辅助人员考试真题2024
- 量子计算入门:通过线性代数学习量子计算 课件 第1章 量子奇旅
- 烟火爆竹安全教育培训
- 2025至2030中国羟基封端的聚丁二烯(HTPB)行业项目调研及市场前景预测评估报告
- DB11-T 695-2025 建筑工程资料管理规程
- 中央党校师资管理制度
评论
0/150
提交评论